Amble Health vs Mochi Health vs Yucca Health (2026)
On tirzepatide, the order is Yucca Health↗ ($258) → Mochi Health↗ ($278) → Amble Health ($300) — gaps of $20 and then $22 a month, a $504 spread across a year between first and last. All-in figures, 10 mg basis, captured 2026-08-09.
Updated 2026-08-10 · figures captured 2026-08-09 · how we verify
The three records, one screen
Yucca Health: the record, condensed
On tirzepatide, the number that matters at Yucca Health is $258 a month all-in — the figure at the 10 mg maintenance basis this whole site ranks on. The price is dose-flat: the standard titration ladder (2.5 → 5 → 7.5 → 10 mg (12.5 and 15 mg available)) is financially invisible here, because the top rung bills exactly what the bottom rung billed. That converts the advertised number from a floor into a ceiling — the strongest single structural feature a program in this category can have.
The absence worth noticing: no mandatory membership. Across this index memberships run $25–$145 a month and hide outside headline prices; here the headline is the bill.
Context for that figure: it ranks #2 of 17 in the verified tirzepatide index — $43/month above the floor (NexLife↗, $215) — and sits $191 under the brand benchmark (Zepbound (LillyDirect↗), $449 at maintenance). Annualized, a monthly-billed year here runs $3,096.
Start with the load-bearing figure: $146 a month, all-in, is what Yucca Health charges for semaglutide at the 2.4 mg basis. Because pricing is flat across the ladder (0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg), a dose increase at Yucca Health is a clinical event and not a billing one. Whatever your prescriber decides, the invoice does not move, which makes this one of the few programs whose headline figure you can actually plan a year around.
The absence worth noticing: no mandatory membership. Across this index memberships run $25–$145 a month and hide outside headline prices; here the headline is the bill.
To place the number: #2 of 20 verified programs, with the floor $13/month below at Oak Longevity ($133); the approved-product yardstick (Wegovy (NovoCare↗)) sits at $349, so the compounded case here is worth $203 a month. A year at this figure: $1,752 monthly-billed.
Operationally at Yucca Health: shipping included; commitment 6-month term; cancellation 6-month term applies; pharmacy not publicly named — ask in writing before paying; states: not published; evidence source-verified, captured 2026-08-05. The full record with source and archive links: the Yucca Health page · visit Yucca Health ↗
Mochi Health: the record, condensed
On tirzepatide, the number that matters at Mochi Health is $278 a month all-in — the figure at the 10 mg maintenance basis this whole site ranks on. It is a flat structure: 2.5 → 5 → 7.5 → 10 mg (12.5 and 15 mg available) all bill identically. In a market where most low advertised prices quietly belong to the starter dose, a flat figure is the difference between a quote and a teaser.
Inside that $278 sits a mandatory $79-a-month membership. We fold it in automatically — the medication-only figure the marketing may lead with is $199, and it is not a price anyone can actually pay, because the membership cannot be declined.
To place the number: #4 of 17 verified programs, with the floor $63/month below at NexLife ($215); the approved-product yardstick (Zepbound (LillyDirect)) sits at $449, so the compounded case here is worth $171 a month. A year at this figure: $3,336 monthly-billed.
Start with the load-bearing figure: $178 a month, all-in, is what Mochi Health charges for semaglutide at the 2.4 mg basis. It is a flat structure: 0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg all bill identically. In a market where most low advertised prices quietly belong to the starter dose, a flat figure is the difference between a quote and a teaser.
The all-in figure already contains a compulsory $79 monthly membership. That is the honest way to quote it: a bundled price is only misleading when its parts are advertised separately, and here the medication-only $99 would be exactly that kind of mirage.
Context for that figure: it ranks #8 of 20 in the verified semaglutide index — $45/month above the floor (Oak Longevity, $133) — and sits $171 under the brand benchmark (Wegovy (NovoCare), $349 at maintenance). Annualized, a monthly-billed year here runs $2,136.
Operationally at Mochi Health: shipping included; commitment membership recurs monthly; cancellation cancel membership any time; recurs until cancelled; pharmacy named (company-owned compounding facility); states: most states; evidence source-verified, captured 2026-08-05. The full record with source and archive links: the Mochi Health page · visit Mochi Health ↗
Amble Health: the record, condensed
Amble Health’s tirzepatide program bills $300 a month once every mandatory fee is counted, measured at the 10 mg maintenance basis. Because pricing is flat across the ladder (2.5 → 5 → 7.5 → 10 mg (12.5 and 15 mg available)), a dose increase at Amble Health is a clinical event and not a billing one. Whatever your prescriber decides, the invoice does not move, which makes this one of the few programs whose headline figure you can actually plan a year around.
Nothing recurs on top: no membership, no platform fee, no “provider access” line. The $300 is the whole subscription, which makes Amble Health unusually easy to compare and unusually easy to leave.
Context for that figure: it ranks #9 of 17 in the verified tirzepatide index — $85/month above the floor (NexLife, $215) — and sits $149 under the brand benchmark (Zepbound (LillyDirect), $449 at maintenance). Annualized, a monthly-billed year here runs $3,600.
Operationally at Amble Health: shipping unknown; commitment unknown; cancellation not published; pharmacy not publicly named — ask in writing before paying; states: not published; evidence third-party reported, captured 2026-08-05. The full record with source and archive links: the Amble Health page
Prices, gaps, and what sits inside them
Yucca Health holds the low ground at $258 — dose-flat, so that figure is a ceiling with no membership attached. Mochi Health follows at $278 (+$20/mo, $240/yr), membership included. Amble Health tops the trio at $300 (+$42/mo over the leader, $504/yr) — note its record’s watch-out below.
The semaglutide picture reshuffles nothing: Yucca Health $146 → Mochi Health $178 — a reminder that molecule choice and provider choice are separate decisions, priced separately in the semaglutide index.
Who wins what
Cheapest month-to-month: Yucca Health ($258); cheapest 12-month path: Yucca Health ($3,096); simplest billing (no membership): Yucca Health and Amble Health; named-pharmacy transparency: Mochi Health; cheapest semaglutide of the three: Yucca Health ($146).
Every winner above is a computation, not a placement; the pairwise pages carry the full duels: Yucca Health vs Mochi Health · Yucca Health vs Amble Health (record · record) · Mochi Health vs Amble Health (record · record).
Everything besides the three prices
Memberships: Yucca Health none; Mochi Health $79/mo (inside its figure); Amble Health none. Structures: Yucca Health dose-flat; Mochi Health dose-flat; Amble Health dose-flat. Pharmacies: Yucca Health not named; Mochi Health named (company-owned compounding facility); Amble Health not named. States: Yucca Health — not published; Mochi Health — most states; Amble Health — not published. Exit terms: Yucca Health — 6-month term applies; Mochi Health — cancel membership any time; recurs until cancelled; Amble Health — not published.
The census reading: where all three match on an axis, that axis cannot break the tie and the price column rules; where they split — a membership here, an unnamed pharmacy there — the split is usually worth more than a small price gap, because structure is what you live with after month one. Evidence for all three: Yucca Health source-verified (2026-08-05); Mochi Health source-verified (2026-08-05); Amble Health third-party reported (2026-08-05).
The trio on semaglutide, across time
3 mo: Yucca Health $438 vs Mochi Health $534 6 mo: Yucca Health $876 vs Mochi Health $1,068 12 mo: Yucca Health $1,752 vs Mochi Health $2,136 — monthly-billed totals; prepaid paths where published appear on each provider page.
The trio, annualized
Yucca Health: $3,096/yr monthly-billed; Mochi Health: $3,336/yr monthly-billed; Amble Health: $3,600/yr monthly-billed. Across two years at monthly billing the first-to-last spread widens to $1,008 — the horizon at which structure (prepaid ladders, flat pricing, membership drag) matters more than the sticker.
The elimination read
Work it as eliminations rather than a beauty contest. Amble Health enters owing an explanation: $42/month above Yucca Health compounds to $504 a year — real therapy-months of money — so its record has to name what the premium buys (structure the cheaper two lack) or it exits first. Mochi Health survives the first cut only to face the harder question — whether its $79/mo membership bundles services the floor does not is worth $20 a month to you — because a middle option that cannot answer it is just the expensive option with better camouflage. Yucca Health is what remains: the arithmetic answer at $258, dethroned only by a state gap, a structural need, or a prescriber’s judgment — the three things this page deliberately cannot decide.
The same trio on best published rate: Yucca Health $258 → Mochi Health $278 → Amble Health $300 — all three price month-to-month only at capture. Short-horizon totals, monthly-billed: 3 months — Yucca Health $774, Mochi Health $834, Amble Health $900; 6 months — Yucca Health $1,548, Mochi Health $1,668, Amble Health $1,800. 0 of the three publish a prepaid path below their own monthly billing; the twelve- and twenty-four-month table below carries those, labeled.
Grade the three records before trusting the three prices. On the five-point disclosure checklist (price, pharmacy, states, cancellation, source-verification): Yucca Health 4/5 · Mochi Health 5/5 · Amble Health 3/5. The gap between Mochi Health (5/5) and Amble Health (3/5) is itself information: undisclosed axes are where the questions in each provider’s review earn their keep. The concrete splits — pharmacy named: Mochi Health yes, Yucca Health and Amble Health no — convert directly into pre-purchase emails. Every score is a computation from the dataset, contestable at the corrections desk like any other figure.
The three-way verdict compresses cleanly: Yucca Health is the default on arithmetic; Mochi Health earns the middle only where its structure (membership services) solves something the floor does not; and Amble Health’s $42/month premium over the leader — $504 a year, roughly 2.0 extra months of therapy at the floor rate — needs a named justification from its record, not a vibe. Insurance coverage, where it exists, outranks all three.
Frequently asked
Which is cheapest: Amble Health, Mochi Health, or Yucca Health?
Yucca Health, at $258/month all-in tirzepatide — $20 under Mochi Health and $42 under Amble Health; on semaglutide the cheapest of the three is Yucca Health at $146. Captured 2026-08-09.
Which of the three is best over a full year?
Yucca Health’s best path prices twelve months at $3,096; monthly-billed years run Yucca Health $3,096, Mochi Health $3,336, Amble Health $3,600.
Are these rankings paid or editorial?
Neither — they are sorts of the public dataset on the all-in maintenance basis, regenerated on every data change; the methodology page defines the basis and the JSON lets you recompute every figure here.